| Literature DB >> 31531615 |
Karoline Silveira1, Leila John Marques Steidle2, Darlan Laurício Matte3, Pedro Heliodoro Tavares4, Mariangela Pimentel Pincelli2, Marcia Margaret Menezes Pizzichini2, Emilio Pizzichini2,5,6, Surinder Singh Birringer7, Michelle Gonçalves de Souza Tavares1,3.
Abstract
OBJECTIVE: To translate the King's Brief Interstitial Lung Disease (K-BILD) questionnaire to Portuguese and culturally adapt it for use in Brazil. The K-BILD quantifies the health status of patients with ILD.Entities:
Mesh:
Year: 2019 PMID: 31531615 PMCID: PMC7247763 DOI: 10.1590/1806-3713/e20180194
Source DB: PubMed Journal: J Bras Pneumol ISSN: 1806-3713 Impact factor: 2.624
Figure 1Summary of the process of translation and cross-cultural adaptation of the King’s Brief Interstitial Lung Disease (K-BILD) questionnaire to Brazilian Portuguese.
Characteristics of the participants in the study (N = 20).a
| Characteristic | Result |
|---|---|
| Age, yearsb | 59 (32-77) |
| Gender | |
| Female | 14 |
| Male | 6 |
| Ethnicity | |
| White | 16 |
| Brown | 3 |
| Indigenous | 1 |
| Level of education | |
| Primary education | 10 |
| Secondary education | 8 |
| Higher education | 2 |
| Diagnosis of ILD | |
| Interstitial lung disease secondary to collagen disease | 3 |
| Idiopathic pulmonary fibrosis | 5 |
| Nonspecific interstitial pneumonia | 6 |
| Chronic hypersensitivity pneumonitis | 3 |
| Alveolar proteinosis | 2 |
| Sarcoidosis | 1 |
| mMRC scale score | |
| 0 | 3 |
| 2 | 9 |
| 3 | 5 |
| 4 | 3 |
| Associated morbidities | |
| Systemic arterial hypertension | 12 |
| Dyslipidemia | 6 |
| Chronic kidney disease | 2 |
| Gastroesophageal reflux disease | 1 |
| Diabetes mellitus | 1 |
| Pulmonary functionc | |
| FEV1, % of predicted | 65.5 (56.2-76.7) |
| FVC,% of predicted | 66.5 (57.7-83.7) |
| FEV1/FVC % of predicted | 98.5 (92.5-108.5) |
ILD: interstitial lung disease; and mMRC: modified Medical Research Council scale. aValues expressed in n, except where otherwise indicated. bValues expressed in median (minimum-maximum). cValues in median [interquartile range]. Reference values according to Crapo et al. Patients evaluated while using their control medication, prior to the use of bronchodilators.